Literature DB >> 21607113

Human pluripotent stem cells: from biology to cell therapy.

Jean-Marie Ramirez1, Qiang Bai, Marilyne Dijon-Grinand, Said Assou, Sabine Gerbal-Chaloin, Samir Hamamah, John De Vos.   

Abstract

Human pluripotent stem cells (PSCs), encompassing embryonic stem cells and induced pluripotent stem cells, proliferate extensively and differentiate into virtually any desired cell type. PSCs endow regenerative medicine with an unlimited source of replacement cells suitable for human therapy. Several hurdles must be carefully addressed in PSC research before these theoretical possibilities are translated into clinical applications. These obstacles are: (1) cell proliferation; (2) cell differentiation; (3) genetic integrity; (4) allogenicity; and (5) ethical issues. We discuss these issues and underline the fact that the answers to these questions lie in a better understanding of the biology of PSCs. To contribute to this aim, we have developed a free online expression atlas, Amazonia!, that displays for each human gene a virtual northern blot for PSC samples and adult tissues (http://www.amazonia.transcriptome.eu).

Entities:  

Keywords:  Cell differentiation; Cell proliferation; Cell reprogramming; Embryonic stem cells; Pluripotent stem cells; Therapeutics

Year:  2010        PMID: 21607113      PMCID: PMC3097919          DOI: 10.4252/wjsc.v2.i2.24

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  96 in total

1.  Abate and switch: miR-145 in stem cell differentiation.

Authors:  Raghu R Chivukula; Joshua T Mendell
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

2.  Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.

Authors:  Ludovic Vallier; Sasha Mendjan; Stephanie Brown; Zhenzhi Chng; Adrian Teo; Lucy E Smithers; Matthew W B Trotter; Candy H-H Cho; Amelie Martinez; Peter Rugg-Gunn; Gabrielle Brons; Roger A Pedersen
Journal:  Development       Date:  2009-03-11       Impact factor: 6.868

3.  A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity.

Authors:  Rosa M Marión; Katerina Strati; Han Li; Matilde Murga; Raquel Blanco; Sagrario Ortega; Oscar Fernandez-Capetillo; Manuel Serrano; Maria A Blasco
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

4.  Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells.

Authors:  Guangjin Pan; Shulan Tian; Jeff Nie; Chuhu Yang; Victor Ruotti; Hairong Wei; Gudrun A Jonsdottir; Ron Stewart; James A Thomson
Journal:  Cell Stem Cell       Date:  2007-09-13       Impact factor: 24.633

5.  The Ink4/Arf locus is a barrier for iPS cell reprogramming.

Authors:  Han Li; Manuel Collado; Aranzazu Villasante; Katerina Strati; Sagrario Ortega; Marta Cañamero; Maria A Blasco; Manuel Serrano
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

6.  Histone modifications at human enhancers reflect global cell-type-specific gene expression.

Authors:  Nathaniel D Heintzman; Gary C Hon; R David Hawkins; Pouya Kheradpour; Alexander Stark; Lindsey F Harp; Zhen Ye; Leonard K Lee; Rhona K Stuart; Christina W Ching; Keith A Ching; Jessica E Antosiewicz-Bourget; Hui Liu; Xinmin Zhang; Roland D Green; Victor V Lobanenkov; Ron Stewart; James A Thomson; Gregory E Crawford; Manolis Kellis; Bing Ren
Journal:  Nature       Date:  2009-03-18       Impact factor: 49.962

7.  Linking the p53 tumour suppressor pathway to somatic cell reprogramming.

Authors:  Teruhisa Kawamura; Jotaro Suzuki; Yunyuan V Wang; Sergio Menendez; Laura Batlle Morera; Angel Raya; Geoffrey M Wahl; Juan Carlos Izpisúa Belmonte
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

8.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures.

Authors:  Mark H Chin; Mike J Mason; Wei Xie; Stefano Volinia; Mike Singer; Cory Peterson; Gayane Ambartsumyan; Otaren Aimiuwu; Laura Richter; Jin Zhang; Ivan Khvorostov; Vanessa Ott; Michael Grunstein; Neta Lavon; Nissim Benvenisty; Carlo M Croce; Amander T Clark; Tim Baxter; April D Pyle; Mike A Teitell; Matteo Pelegrini; Kathrin Plath; William E Lowry
Journal:  Cell Stem Cell       Date:  2009-07-02       Impact factor: 24.633

9.  Chd1 regulates open chromatin and pluripotency of embryonic stem cells.

Authors:  Alexandre Gaspar-Maia; Adi Alajem; Fanny Polesso; Rupa Sridharan; Mike J Mason; Amy Heidersbach; João Ramalho-Santos; Michael T McManus; Kathrin Plath; Eran Meshorer; Miguel Ramalho-Santos
Journal:  Nature       Date:  2009-07-08       Impact factor: 49.962

10.  Lysophosphatidic acid inhibits neuronal differentiation of neural stem/progenitor cells derived from human embryonic stem cells.

Authors:  Mirella Dottori; Jessie Leung; Ann M Turnley; Alice Pébay
Journal:  Stem Cells       Date:  2008-02-28       Impact factor: 6.277

View more
  6 in total

1.  Spermatogonial stem cells: Current biotechnological advances in reproduction and regenerative medicine.

Authors:  Pedro Manuel Aponte
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

Review 2.  Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective.

Authors:  Qiang Bai; Romain Desprat; Bernard Klein; Jean-Marc Lemaître; John De Vos
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

Review 3.  Allogenic banking of dental pulp stem cells for innovative therapeutics.

Authors:  Pierre-Yves Collart-Dutilleul; Franck Chaubron; John De Vos; Frédéric J Cuisinier
Journal:  World J Stem Cells       Date:  2015-08-26       Impact factor: 5.326

4.  Mesenchymal stem cells in maxillary sinus augmentation: A systematic review with meta-analysis.

Authors:  Francesco G Mangano; Marco Colombo; Giovanni Veronesi; Alberto Caprioglio; Carlo Mangano
Journal:  World J Stem Cells       Date:  2015-07-26       Impact factor: 5.326

5.  Dissecting the first transcriptional divergence during human embryonic development.

Authors:  Qiang Bai; Said Assou; Delphine Haouzi; Jean-Marie Ramirez; Cécile Monzo; Fabienne Becker; Sabine Gerbal-Chaloin; Samir Hamamah; John De Vos
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

6.  Next-generation sequencing traces human induced pluripotent stem cell lines clonally generated from heterogeneous cancer tissue.

Authors:  Tetsuya Ishikawa
Journal:  World J Stem Cells       Date:  2017-05-26       Impact factor: 5.326

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.